Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  TERT-BUTYL 3-OXO-2,8-DIAZASPIRO[4.5]DECANE-8-CARBOXYLATE

TERT-BUTYL 3-OXO-2,8-DIAZASPIRO[4.5]DECANE-8-CARBOXYLATE

Basic information Safety Supplier Related

TERT-BUTYL 3-OXO-2,8-DIAZASPIRO[4.5]DECANE-8-CARBOXYLATE Basic information

Product Name:
TERT-BUTYL 3-OXO-2,8-DIAZASPIRO[4.5]DECANE-8-CARBOXYLATE
Synonyms:
  • TERT-BUTYL 3-OXO-2,8-DIAZASPIRO[4.5]DECANE-8-CARBOXYLATE
  • 2,8-diazaspiro[4.5]decane-8-carboxylic acid, 3-oxo-, 1,1-d
  • 8-Boc-3-oxo-2,8-diazaspir...
  • 8-Boc-3-oxo-2,8-diazaspiro[4.5]decane
  • 2,8-Diazaspiro[4.5]decane-8-carboxylic acid,3-oxo-,1,1-diMethylethyl ester
  • 3-keto-2,8-diazaspiro[4.5]decane-8-carboxylic acid tert-butyl ester
  • tert-Butyl 2-oxo-3,8-diazaspiro[4.5]decane-8-carboxylate
  • 8-Boc-2,8-diazaspiro[4.5]decan-3-one
CAS:
169206-67-1
MF:
C13H22N2O3
MW:
254.33
Mol File:
169206-67-1.mol
More
Less

TERT-BUTYL 3-OXO-2,8-DIAZASPIRO[4.5]DECANE-8-CARBOXYLATE Chemical Properties

Boiling point:
425℃
Density 
1.15
Flash point:
211℃
storage temp. 
2-8°C
pka
16.26±0.20(Predicted)
Appearance
White to light yellow Solid
More
Less

Safety Information

HazardClass 
IRRITANT
HS Code 
2933998090
More
Less

TERT-BUTYL 3-OXO-2,8-DIAZASPIRO[4.5]DECANE-8-CARBOXYLATE Usage And Synthesis

Uses

Tert-butyl 3-oxo-2,8-diazaspiro[4.5]decane-8-carboxylate is an organic heterocyclic compound used as a pharmaceutical intermediate. It is used in the synthesis of growth inhibitor receptor 5 (SSTR5) antagonists for the treatment of conditions involving the gut-brain axis.

Synthesis

169206-66-0

169206-67-1

General procedure for the synthesis of tert-butyl 3-oxo-2,8-diazaspiro[4,5]decane-8-carboxylate from tert-butyl 4-(2-methoxy-2-oxoethyl)-4-(nitromethyl)piperidine-1-carboxylate: To a tert-butyl 4-(2-methoxy-2-oxoethyl)-4-(nitromethyl)piperidine-1-carboxylate (1.0 g, 3.2 mmol) ethanol ( 10 mL) solution was added to Raney Ni (1 g). The reaction mixture was stirred under hydrogen atmosphere at 1 atmosphere overnight. Upon completion of the reaction, the mixture was filtered through a diatomaceous earth pad to remove the catalyst and the filtrate was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography using a dichloromethane solution of 10% methanol as eluent to afford the target product tert-butyl 3-oxo-2,8-diazaspiro[4,5]decane-8-carboxylate (694 mg, 86% yield). The structure of the product was confirmed by 1H NMR (400 MHz, CD3OD): δ 3.54-3.48 (m, 2H), 3.37-3.32 (m, 2H), 3.23 (s, 2H), 2.26 (s, 2H), 1.62-1.59 (m, 4H), 1.45 (s, 9H).

References

[1] Patent: US2006/19985, 2006, A1. Location in patent: Page/Page column 55
[2] Journal of Medicinal Chemistry, 1995, vol. 38, # 19, p. 3772 - 3779
[3] Bioorganic and Medicinal Chemistry, 2018, vol. 26, # 14, p. 3866 - 3874
[4] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 22, p. 6375 - 6378
[5] Patent: WO2015/140559, 2015, A1. Location in patent: Page/Page column 44

TERT-BUTYL 3-OXO-2,8-DIAZASPIRO[4.5]DECANE-8-CARBOXYLATESupplier

PharmaBlock Sciences (Nanjing),Inc.
Tel
025-86918202 4000255188
Email
sales@pharmablock.com
Tetranov Biopharm
Tel
13526569071
Email
sales@leadmedpharm.com
Shanghai Boc Chemical Co.,Ltd
Tel
021-34975603-808 18721111801
Email
sales@bocpharma.com
Santai Labs, Inc.
Tel
519-85601385
Email
marketing@santailabs.com
Atop-Pharma (Shanghai) Technology Co., Ltd.
Tel
+86 (21) 5196-9732